The evaluation of amifostine for mucosal protection in patients with advanced loco-regional Squamous Cell Carcinomas of the Head and Neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily Radiotherapy (RT)

This publication has 18 references indexed in Scilit:

• The use of carboplatin and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck
  International Journal of Radiation Oncology*Biology*Physics, 2000
• Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data
  The Lancet, 2000
• Radiation Therapy With Concomitant Hydroxyurea and Fluorouracil in Stage II and III Head and Neck Cancer
  Journal of Clinical Oncology, 1999
• Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.
  Journal of Clinical Oncology, 1998
• Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study.
  Journal of Clinical Oncology, 1998
• Altered fractionation in the management of head and neck cancer.
  International Journal of Radiation Biology, 1998
• Larynx Preservation in Pyriform Sinus Cancer: Preliminary Results of a European Organization for Research and Treatment of Cancer Phase III Trial
  JNCI Journal of the National Cancer Institute, 1996
• Chemotherapy for squamous cell carcinoma of head and neck: The future is now
  Annals of Oncology, 1996
• Protection of Normal Tissue from the Cytotoxic Effects of Chemotherapy and Radiation by Amifostine: Clinical Experiences
  European Journal Of Cancer, 1995
• Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck. An RTOG study
  Cancer, 1987